Literature DB >> 9182244

Differentiation by magnesium ions of affinities of nuclear proteins for consensus core nucleotide element of the transcription factor c-Myc in murine brain.

K Ogita1, T Amizuka, Y Azuma, Y Yoneda.   

Abstract

The addition of divalent cations such as Mg(2+) and Ca(2+) ions markedly reduced binding of a radiolabeled double stranded oligonucleotide probe for the transcription factor c-Myc in the presence of 100 mM KCl in nuclear extracts of the mouse whole brain. Irrespective of the addition of MgCl(2), binding was selectively competed with the unlabeled probe for c-Myc having a double stranded conformation. Treatment with V8 protease differentially modulated binding of the probe for c-Myc determined in the presence and absence of added MgCl(2). Introduction of irreversible covalent bonding between the radiolabeled probe and nuclear proteins led to retarded mobility of the radioactive probe/protein complex in the presence of MgCl(2) on sodium dodecyl sulfate electrophoresis regardless of treatment with DNase. However, an antibody against the c-Myc protein affected neither mobility nor intensity of the radioactive band on gel retardation electrophoresis. Moreover, regional distribution was different from each other in mouse brain when determined in the presence and absence of added MgCl(2). These results suggest that magnesium ions may have an ability to differentiate between nuclear c-Myc family proteins with different affinities for the consensus core nucleotide element CACGTG in murine brain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9182244     DOI: 10.1007/BF02529136

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

1.  Myc and Max associate in vivo.

Authors:  E M Blackwood; B Lüscher; R N Eisenman
Journal:  Genes Dev       Date:  1992-01       Impact factor: 11.361

2.  Generalized seizures induce c-fos protein(s) in mammalian neurons.

Authors:  M Dragunow; H A Robertson
Journal:  Neurosci Lett       Date:  1987-11-23       Impact factor: 3.046

3.  Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain.

Authors:  P Sassone-Corsi; L J Ransone; W W Lamph; I M Verma
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

4.  Mapping patterns of c-fos expression in the central nervous system after seizure.

Authors:  J I Morgan; D R Cohen; J L Hempstead; T Curran
Journal:  Science       Date:  1987-07-10       Impact factor: 47.728

5.  In primary cultures of cerebellar granule cells the activation of N-methyl-D-aspartate-sensitive glutamate receptors induces c-fos mRNA expression.

Authors:  A M Szekely; M L Barbaccia; H Alho; E Costa
Journal:  Mol Pharmacol       Date:  1989-04       Impact factor: 4.436

Review 6.  Function of the c-Myc oncoprotein.

Authors:  G J Kato; C V Dang
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

7.  Selectively high expression of the transcription factor AP1 in telencephalic structures of epileptic E1 mice.

Authors:  Y Yoneda; K Ogita; H Kabutoz; A Mori
Journal:  Neurosci Lett       Date:  1993-10-29       Impact factor: 3.046

8.  Rapid potentiation of DNA binding activities of particular transcription factors with leucine-zipper motifs in discrete brain structures of the gerbil with transient forebrain ischemia.

Authors:  Y Yoneda; K Ogita; K Inoue; A Mitani; L Zhang; S Masuda; M Higashihara; K Kataoka
Journal:  Brain Res       Date:  1994-12-19       Impact factor: 3.252

9.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.

Authors:  A S Zervos; J Gyuris; R Brent
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

10.  Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle.

Authors:  P H Rabbitts; J V Watson; A Lamond; A Forster; M A Stinson; G Evan; W Fischer; E Atherton; R Sheppard; T H Rabbitts
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.